The ACCENT trial (Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment method), which began enrollment in 2014 which is now in Period three underneath the purview of UCLA, which examined using N-Acetylcysteine as a potential Resource for cannabis cessation in adult contributors. Its content is presently undergoing review and is unpublished at https://georgec792hjk6.goabroadblog.com/profile